On ECHEMI
Home > Drugs > Wuhan Fuxing BIO- Pharmaceutical Co., Ltd.
Wuhan Fuxing BIO- Pharmaceutical Co., Ltd.
  • Founded in:

    2002-10-17
  • Country:

    China China
  • Address:

    No. 9, Fuxing Road, Hanchuan Economic Development Zone, Hubei Province
  • Tax NO.:

    91420984741439934X
  • Registered Funds:

    100 million yuan
  • Website:

  • Email:

Related Drugs
Inosine injection
Chemical name: 9beta;-D-ribosyl hypoxanthine, molecular formula: C10H12N4O5
Name Description Content CAS NO. Registered Holders
9beta;-D-ribosyl hypoxanthine

This product can directly penetrate the cell membrane into the body cells, activate pyruvate oxidase, so that cells in a low-energy and hypoxic state can continue to metabolize smoothly, and participate in the energy metabolism and protein synthesis of the human body.

More

This product can directly penetrate the cell membrane into the body cells, activate pyruvate oxidase, so that cells in a low-energy and hypoxic state can continue to metabolize smoothly, and participate in the energy metabolism and protein synthesis of the human body.

0
Vitamin B6 Injection
The main ingredient of this product is vitamin B6. Its chemical name is 6-methyl-5-hydroxy-3,4-pyridine dimethanol hydrochloride.
Name Description Content CAS NO. Registered Holders
Vitamin B6

Vitamin B6 is converted into pyridoxal phosphate in red blood cells and acts as a coenzyme in various metabolic functions of proteins, carbohydrates, and lipids. It is also involved in the conversion of tryptophan into niacin or 5-hydroxytryptamine.

More

Vitamin B6 is converted into pyridoxal phosphate in red blood cells and acts as a coenzyme in various metabolic functions of proteins, carbohydrates, and lipids. It is also involved in the conversion of tryptophan into niacin or 5-hydroxytryptamine.

8059-24-3 13
Sodium Bicarbonate Injection
The main ingredient of this product is: sodium bicarbonate.
Name Description Content CAS NO. Registered Holders
Sodium bicarbonate

①. Treat metabolic acidosis. This product increases the concentration of carbonate in plasma and neutralizes hydrogen ions, thereby correcting acidosis. ②. Alkalinize urine. As the pH value increases after the concentration of carbonate in urine increases, uric acid, sulfonamide drugs and hemoglobin are not easy to form crystals or aggregate in urine. ③. Acid antacid. Oral administration can quickly neutralize or buffer gastric acid without directly affecting gastric acid secretion. Therefore, the pH in the stomach increases rapidly to relieve the symptoms caused by high gastric acid.

More

①. Treat metabolic acidosis. This product increases the concentration of carbonate in plasma and neutralizes hydrogen ions, thereby correcting acidosis. ②. Alkalinize urine. As the pH value increases after the concentration of carbonate in urine increases, uric acid, sulfonamide drugs and hemoglobin are not easy to form crystals or aggregate in urine. ③. Acid antacid. Oral administration can quickly neutralize or buffer gastric acid without directly affecting gastric acid secretion. Therefore, the pH in the stomach increases rapidly to relieve the symptoms caused by high gastric acid.

144-55-8 44
Compound Quinine Injection
The main ingredients of this product are: Compound Quinine
Name Description Content CAS NO. Registered Holders
Quinine

Quinine is a quinoline derivative that can bind to the DNA of malarial parasites to form a complex that inhibits DNA replication and RNA transcription, thereby inhibiting the protein synthesis of the protozoa. In addition, quinine can reduce the oxygen consumption of malarial parasites, inhibit the phosphorylase in malarial parasites and interfere with their sugar metabolism. Quinine also causes hemochromatin aggregation, and the nucleus and outer membrane of the protozoa are swollen, with small vacuoles, and blood cell granules aggregated in the small vacuoles. In the blood, a certain concentration of quinine can cause premature rupture of parasitized red blood cells, thereby preventing the maturation of schizonts. This product is ineffective in the early stage of malaria, and a long course of treatment can cure malignant malaria, but it has no direct effect on the gametocytes of malignant malaria, so it cannot interrupt transmission.

More

Quinine is a quinoline derivative that can bind to the DNA of malarial parasites to form a complex that inhibits DNA replication and RNA transcription, thereby inhibiting the protein synthesis of the protozoa. In addition, quinine can reduce the oxygen consumption of malarial parasites, inhibit the phosphorylase in malarial parasites and interfere with their sugar metabolism. Quinine also causes hemochromatin aggregation, and the nucleus and outer membrane of the protozoa are swollen, with small vacuoles, and blood cell granules aggregated in the small vacuoles. In the blood, a certain concentration of quinine can cause premature rupture of parasitized red blood cells, thereby preventing the maturation of schizonts. This product is ineffective in the early stage of malaria, and a long course of treatment can cure malignant malaria, but it has no direct effect on the gametocytes of malignant malaria, so it cannot interrupt transmission.

130-95-0 0
Caffeine

Small doses act on the higher centers of the cerebral cortex, promoting mental excitement, while larger doses can excite the respiratory center and vasomotor center of the medulla oblongata.

More

Small doses act on the higher centers of the cerebral cortex, promoting mental excitement, while larger doses can excite the respiratory center and vasomotor center of the medulla oblongata.

0
Arginine Hydrochloride Injection
The main ingredient of this product is arginine hydrochloride, and its chemical name is L-2-amino-5-guanidine valeric acid hydrochloride.
Name Description Content CAS NO. Registered Holders
L-Arginine hydrochloride

This product participates in the ornithine cycle in the human body, promotes the formation of urea, and converts the ammonia produced in the human body into non-toxic urea through the ornithine cycle and is excreted in the urine, thereby reducing blood ammonia concentration.

More

This product participates in the ornithine cycle in the human body, promotes the formation of urea, and converts the ammonia produced in the human body into non-toxic urea through the ornithine cycle and is excreted in the urine, thereby reducing blood ammonia concentration.

1119-34-2 25
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.